BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22446458)

  • 1. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
    Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
    J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
    Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
    Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.
    Ram S; Siar CH
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):521-7. PubMed ID: 16053872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations.
    Kerr AR; Sirois DA; Epstein JB
    J Clin Dent; 2006; 17(3):59-63. PubMed ID: 17022366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
    Nagaraju K; Prasad S; Ashok L
    Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
    Epstein JB; Sciubba J; Silverman S; Sroussi HY
    Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
    Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
    Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
    Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
    Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
    Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions.
    Cancela-Rodríguez P; Cerero-Lapiedra R; Esparza-Gómez G; Llamas-Martínez S; Warnakulasuriya S
    J Oral Pathol Med; 2011 Apr; 40(4):300-4. PubMed ID: 21426401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
    Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
    Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toluidine blue staining for detection of oral squamous carcinoma].
    Wiersma AC; van der Waal I
    Ned Tijdschr Tandheelkd; 1990 Oct; 97(10):431-2. PubMed ID: 2130265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions.
    Farah CS; McCullough MJ
    Oral Oncol; 2007 Sep; 43(8):820-4. PubMed ID: 17169603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic clinical aids in oral cancer.
    Seoane Lestón J; Diz Dios P
    Oral Oncol; 2010 Jun; 46(6):418-22. PubMed ID: 20371204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions.
    Güneri P; Epstein JB; Kaya A; Veral A; Kazandı A; Boyacioglu H
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):155-61. PubMed ID: 21112183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A community-based RCT for oral cancer screening with toluidine blue.
    Su WW; Yen AM; Chiu SY; Chen TH
    J Dent Res; 2010 Sep; 89(9):933-7. PubMed ID: 20525960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB; Zhang L; Rosin M
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of oral soft-tissue lesions: the use of biopsy, toluidine blue staining, and brush biopsy.
    Handlers JP
    J Calif Dent Assoc; 2001 Aug; 29(8):602-6. PubMed ID: 11577671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
    Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
    J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
    Onofre MA; Sposto MR; Navarro CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.